Recent Developments in the Regulation of Heritable Human Genome Editing

Area of Science:

• Biotechnology
• Genetics
• Bioethics

Background:

• He Jiankui's 2018 announcement of gene-edited human embryos and live births at the Second International Summit on Human Genome Editing.
• This event exposed significant regulatory and legal gaps concerning heritable human genome editing (HHGE).
• The scientific community largely deemed the technology premature for human trials.

Purpose of the Study:

• To review the Third International Summit on Human Genome Editing held in London in March 2023.
• To comment on the latest developments in the regulation of heritable human genome editing.

Main Methods:

• Review of proceedings and discussions from the Third International Summit on Human Genome Editing.
• Analysis of the evolving regulatory landscape and scientific consensus on HHGE.

Main Results:

• The Third Summit addressed the ongoing challenges and progress in establishing regulatory frameworks for HHGE.
• Key discussions focused on ethical considerations, scientific readiness, and international governance of genome editing technologies.

Conclusions:

• Continued international dialogue and collaboration are crucial for responsible development and regulation of HHGE.
• The scientific community's stance emphasizes caution and the need for robust ethical guidelines before widespread application.